Wu Xi App Tec Co., Ltd. Lyell Immunopharma, Inc. Transaction History
Wu Xi App Tec Co., Ltd.
- $19 Billion
- Q3 2024
A detailed history of Wu Xi App Tec Co., Ltd. transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Wu Xi App Tec Co., Ltd. holds 7,390,710 shares of LYEL stock, worth $78.1 Million. This represents 53.56% of its overall portfolio holdings.
Number of Shares
7,390,710
Previous 7,682,156
3.79%
Holding current value
$78.1 Million
Previous $11.1 Billion
8.44%
% of portfolio
53.56%
Previous 47.74%
Shares
3 transactions
Others Institutions Holding LYEL
# of Institutions
16Shares Held
39.5MCall Options Held
0Put Options Held
0-
Apoletto LTD Washington, DC15.1MShares$160 Million42.56% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$143 Million0.0% of portfolio
-
Mwg Management Ltd. Washington, DC1.01MShares$10.7 Million17.17% of portfolio
-
Orland Properties LTD Washington, DC755KShares$7.98 Million2.83% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL641KShares$6.78 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $2.62B
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...